REPORT: Clinical trials for coronavirus treatments begin in New York

MARCH 25, 2020

As the most reliable and balanced news aggregation service on the internet, DML News App offers the following information published by

As New York State continues to see a rise in cases of the novel coronavirus and is the epicenter of the pandemic in the United States, clinical trials for drug treatments began on Tuesday in the state. The state acquired 70,000 doses of hydroxychloroquine, 10,000 doses of zithromax and 750,000 doses of chloroquine in the last few days, according to a news release by New York Gov. Andrew Cuomo’s office.

“We hope for optimistic results,” Cuomo said during a press conference Tuesday, talking about the clinical trials. “The president and the FDA accelerated that drug coming to New York so the hospitals will start using that drug today.”

“About 56% of all the cases in the United States are coming out of that metro area, and 60% of all the new cases are coming out of the metro New York area, and 31% of the people succumbing to this disease,” said Dr. Deborah Birx, the White House coronavirus response coordinator, at Tuesday’s task force press briefing.

In the U.S., nearly half of the national rate affected with coronavirus — 51,000 — stems from New York. The Empire State is also responsible for 131 deaths out of the 674 reported in the country.

“New York is definitely a hot spot, there’s no question about it,” President Donald Trump said Tuesday evening. “And you know what we are doing in New York to try and help, and I think we are doing an incredible job.”


*Coronavirus cases worldwide: 436,024

*Total confirmed deaths: 19,630

*Recovered patients: 111,878

To get more information about this article, please visit To weigh in, leave a comment below.

Leave a comment

Your email address will not be published. Required fields are marked *